SCHEMBL6809967

SCHEMBL6809967

O=[C]Cc1ccc(CCN2CCS(=O)(=O)c3ccccc32)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTT P42858 1/20 0.32
SCN9A Q15858 1/20 0.31
TP53 P04637 2/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31
SIGMAR1 Q99720 1/20 0.30
LMNA P02545 1/20 0.30
PKM P14618 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809969 0.87 CYP1A2 (0.33) CA12CA9CA1CA2CYP1A2
SCHEMBL6809964 0.74 LMNA (0.31) L3MBTL1MAPK1MEN1KMT2ATP53
SCHEMBL4443396 0.74 TP53 (0.38) CA12CA9CA2L3MBTL1MAPK1
SCHEMBL3970320 0.73 MAPK1 (0.36) L3MBTL1MAPK1MEN1KMT2AHTT
SCHEMBL12960882 0.71 HTT (0.41) CA12CA9CA1CA2MAPK1
SCHEMBL4059736 0.68 RXFP1 (0.39) L3MBTL1MAPK1KMT2ATP53LMNA
SCHEMBL3971807 0.68 HDAC6 (0.45) L3MBTL1MAPK1MEN1KMT2A
SCHEMBL6460905 0.67 MEN1 (0.45) MEN1KMT2A
SCHEMBL11995145 0.66 CA2 (0.41) CA12CA9CA1CA2CYP1A2
SCHEMBL3972121 0.65 MAPK1 (0.37) CA12CA9CA1CA2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed